CJC-1295 (With DAC) is a peptide compound recognized for its interaction with growth hormone–related signaling pathways. The DAC
formulation is characterized by extended pathway engagement and prolonged signaling activity compared to non-DAC variants.
This compound is frequently referenced in technical and analytical contexts for its sustained receptor interaction profile and longer-
acting signaling behavior.
